Literature DB >> 19450852

Transurethral partial cystectomy with continuous wave laser for bladder carcinoma.

Yong Yang1, Zhi-tao Wei, Xu Zhang, Bao-Fa Hong, Gang Guo.   

Abstract

PURPOSE: To our knowledge we established a new technique to vaporize and incise the full-thickness bladder wall and peel off the entire muscular layers with a 2 microm continuous wave laser to treat bladder carcinoma.
MATERIALS AND METHODS: Nine patients were treated transurethrally with a 2 microm laser under sacral block. This 2 microm laser was used to incise the full-thickness bladder wall around the tumors. The entire bladder wall was peeled between the detrusor muscle layer and outer connective tissues. Tumors with full-thickness detrusor muscle layers at the base were removed together and sent for pathological examination. Intraoperative hemorrhage and postoperative complications were observed, and pathological staging and postoperative followup were performed.
RESULTS: All operations were successful. Mean +/- SD operative time was 8.7 +/- 2.6 minutes (range 7 to 15) per patient. Perioperative blood loss was minimal. There was no obturator nerve reflection and no hemorrhage was detected after surgery. Bladder perforation occurred in 1 case. Pathological stage of the tumors was T1 and T2a. Patients were followed for 6 to 9 months postoperatively with no recurrence at the resection site. This series included highly selected patients treated by a single high volume surgeon.
CONCLUSIONS: To our knowledge this is the first report of a 2 microm laser used to treat bladder carcinoma. It can be applied to precisely vaporize and incise the full-thickness bladder wall and peel it between detrusor muscle layers and outer loose connective tissues, thus completing partial cystectomy for bladder carcinoma.

Entities:  

Mesh:

Year:  2009        PMID: 19450852     DOI: 10.1016/j.juro.2009.02.154

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  En bloc transurethral resection with 2-micron continuous-wave laser for primary non-muscle-invasive bladder cancer: a randomized controlled trial.

Authors:  Xu Chen; Jun Liao; Lingwu Chen; Shaopeng Qiu; Chengqiang Mo; Xiaopeng Mao; Yuanzhong Yang; Shiying Zhou; Junxing Chen
Journal:  World J Urol       Date:  2014-06-21       Impact factor: 4.226

2.  Comparison of two patients presenting with the clear cell variant of urothelial cell carcinoma of the urinary bladder: laser-assisted partial cystectomy for local disease versus chemotherapy for locally advanced disease.

Authors:  James P Blackmur; Nadja Melquiot; Katherine E Robertson; Seamus Teahan
Journal:  BMJ Case Rep       Date:  2019-06-16

Review 3.  Current evidence for transurethral laser therapy of non-muscle invasive bladder cancer.

Authors:  Mario W Kramer; Thorsten Bach; Mathias Wolters; Florian Imkamp; Andreas J Gross; Markus A Kuczyk; Axel S Merseburger; Thomas R W Herrmann
Journal:  World J Urol       Date:  2011-05-05       Impact factor: 4.226

Review 4.  Current evidence of transurethral Ho:YAG and Tm:YAG treatment of bladder cancer: update 2014.

Authors:  Mario W Kramer; Mathias Wolters; Hannes Cash; Stephan Jutzi; Florian Imkamp; Markus A Kuczyk; Axel S Merseburger; Thomas R W Herrmann
Journal:  World J Urol       Date:  2014-06-17       Impact factor: 4.226

Review 5.  Thulium laser treatment for bladder cancer.

Authors:  Wei Wang; Haitao Liu; Shujie Xia
Journal:  Asian J Urol       Date:  2016-05-25

Review 6.  Management of T1 Urothelial Carcinoma of the Bladder: What Do We Know and What Do We Need To Know?

Authors:  Boris Gershman; Stephen A Boorjian; Richard E Hautmann
Journal:  Bladder Cancer       Date:  2015-09-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.